Enanta Pharmaceuticals Inc (ENTA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-12-31	2024-06-30	2024-03-31	2023-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	11.99% 14.93	16.96	17.97	17.05	18.00
Operating Expenses	2.59% 39.45	40.50	42.16	49.82	52.89
Benefits Costs and Expenses	1.99% 38.88	39.66	41.02	48.57	52.03
Costs And Expenses	2.59% 39.45	40.50	42.16	49.82	52.89
Depreciation and Amortization	35.32% 1.203	0.889	0.594	0.621	0.642
Operating Income/Loss	4.18% -24.53	-23.54	-24.18	-32.77	-34.89
Nonoperating Income/Loss	30.94% 0.578	0.837	1.132	1.246	0.857
Income/Loss From Continuing Operations Before Tax	5.47% -23.95	-22.71	-23.05	-31.52	-34.03
Income Tax Expense/Benefit	213.70% -1.305	-0.416	-0.395	-0.363	-0.622
Income/Loss From Continuing Operations After Tax	1.59% -22.64	-22.29	-22.66	-31.16	-33.41
Net Income/Loss	1.59% -22.64	-22.29	-22.66	-31.16	-33.41
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.55% 21.36	21.24	21.18	21.17	21.09
Diluted Average Shares	0.55% 21.36	21.24	21.18	21.17	21.09
Basic Earnings Per Share	0.95% -1.06	-1.05	-1.07	-1.47	-1.58
Diluted Earnings Per Share	0.95% -1.06	-1.05	-1.07	-1.47	-1.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$34.90

2.43%

INCY

$81.66

2.97%

GMAB

$28.84

2.07%

BNTX

$98.08

1.67%

INSM

$135.59

3.84%

ONC

$328.71

0.34%